2013 annual financial data
Tenax Therapeutics 2013 Operating cash flow
Direct answer
Operating cash flow was -9,261,571 USD.
Operating income was -16,611,120 USD and net income was -19,541,839 USD.
Operating cash flow was -9,261,571 USD.
Get free Tenax Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 288,726 USD
- Operating income
- -16,611,120 USD
- Net income
- -19,541,839 USD
- Operating cash flow
- -9,261,571 USD